These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21440954)

  • 41. Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway.
    Harstad I; Heldal E; Steinshamn SL; Garåsen H; Winje BA; Jacobsen GW
    Scand J Public Health; 2010 May; 38(3):275-82. PubMed ID: 19914972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel screening tools for latent tuberculosis: time to leave an old friend?
    Villiger PM; Zellweger JP; Möller B
    Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cost-effectiveness of screening for latent tuberculosis in healthcare workers].
    Diomedi A
    Rev Chilena Infectol; 2013 Jun; 30(3):330. PubMed ID: 23877785
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees.
    Kowada A
    Am J Infect Control; 2011 Dec; 39(10):e67-72. PubMed ID: 21839543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients.
    Aabye MG; Ruhwald M; Praygod G; Jeremiah K; Faurholt-Jepsen M; Faurholt-Jepsen D; Range N; Friis H; Changalucha J; Andersen AB; Ravn P
    Eur Respir J; 2010 Dec; 36(6):1488-90. PubMed ID: 21119209
    [No Abstract]   [Full Text] [Related]  

  • 46. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
    Martin J; Walsh C; Gibbs A; McDonnell T; Fearon U; Keane J; Codd MB; Dodd J; Veale D; Fitzgerald O; Bresnihan B
    Ann Rheum Dis; 2010 Jan; 69(1):181-5. PubMed ID: 19176545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tuberculosis in healthcare workers, Scotland.
    Pollock KG; McDonald E; Smith-Palmer A; Johnston F; Ahmed S
    Scott Med J; 2017 Aug; 62(3):101-103. PubMed ID: 28836925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: utility of the new IGRAs.
    Cordero-Coma M; Calleja S; Torres HE; del Barrio I; Franco M; Yilmaz T; Vivas S; de Morales JG
    Eye (Lond); 2010 Jan; 24(1):36-43. PubMed ID: 19300463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Screening for tuberculosis].
    Van Vooren JP; Schepers K
    Rev Med Brux; 2013 Sep; 34(4):301-5. PubMed ID: 24195244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Who misses the second step of evaluation in tuberculosis contact screening?
    Soares Pires F; Pinto C; Duarte R
    Eur Respir J; 2011 Aug; 38(2):474-6. PubMed ID: 21804166
    [No Abstract]   [Full Text] [Related]  

  • 54. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indeterminate results of a tuberculosis-specific interferon-gamma release assay in immunocompromised patients.
    Lange B; Vavra M; Kern WV; Wagner D
    Eur Respir J; 2010 May; 35(5):1179-82. PubMed ID: 20436175
    [No Abstract]   [Full Text] [Related]  

  • 56. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers.
    Gandra S; Scott WS; Somaraju V; Wang H; Wilton S; Feigenbaum M
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1279-85. PubMed ID: 20979495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Latent tuberculosis infection and tuberculosis in children and adolescents.
    Ishikawa CS; Matsuo OM; Sarno F
    Einstein (Sao Paulo); 2018 Sep; 16(3):eAO4090. PubMed ID: 30231141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Detection of latent tuberculosis infection in peritoneal dialysis patients: new methods].
    Palomar R; Arias Guillén M; Robledo C; Agüero R; Agüero J; Rodríguez C; Molinos L; Rodrigo E; Ortega F; Arias M
    Nefrologia; 2011; 31(2):169-73. PubMed ID: 21461010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The case detection of tuberculosis through mass x-ray examination: the cost and implications].
    Ruffino-Netto A
    Rev Saude Publica; 2006 Jun; 40(3):400-1. PubMed ID: 16810362
    [No Abstract]   [Full Text] [Related]  

  • 60. Analysis of tuberculosis casefinding in Denver, Colorado, 1965-70.
    Swallow J; Sbarbaro JA
    Health Serv Rep; 1972 Apr; 87(4):375-84. PubMed ID: 5022820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.